Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle platform.

The US Food and Drug Administration (FDA) has approved two of Merck & Co’s (MSD) Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph), each combined with Padcev ...

Patient advocates in remission from MCL and FL discuss their treatment experiences with ASCT and CAR-T, while sharing views on latter's place in the treatment paradigm.

There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.

The proposed rule would allow multiple manufacturing units at different locations to register as one establishment.

Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to PDMPs.

The funds will support the progression of MindRank’s pipeline, which is heavily dominated by obesity indications.

Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus to treat multiple sclerosis.

Apertura has entered a CRADA with various NIH institutes for a gene therapy to treat Niemann-Pick Disease Type C1 (NPC1).

Bayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.

Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues.